Antimicrobial resistance: Its surveillance, impact, and alternative management strategies in dairy animals

Frontiers in Veterinary Science

Volumn 4, Issue JAN, 2018, Pages

  Sharma, Chetan ^a   Rokana, Namita ^a   Chandra, Mudit ^a   Singh, Brij Pal ^a   Gulhane, Rohini Devidas ^a   Gill, Jatinder Paul Singh ^a   Ray, Pallab ^b   Puniya, Anil Kumar ^a   Panwar, Harsh ^a  

^a GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alternative treatment strategies; Antimicrobial resistance; Antimicrobial usage; Dairy farming; Multidrug resistance; Surveillance

Indexed keywords

EID: 85040461976     PISSN: None     EISSN: 22971769     Source Type: Journal    
DOI: 10.3389/fvets.2017.00237     Document Type: Review

References (299)

1. Thakur N, Rokana N, Panwar H. Probiotics: selection criteria, safety and role in health and disease. J Inno Biol (2016) 3(1):259-70
2. Adrio JL, Demain AL. Microbial enzymes: tools for biotechnological processes. Biomolecules (2014) 4(1):117-39. doi:10.3390/biom4010117
3. Kumar A. Role of microbes in food and industrial microbiology. J Food Ind Microbiol (2016) 2:e101. doi:10.4172/2572-4134.1000e101
4. Tamang JP, Shin D, Jung S, Chia S. Functional properties of microorganisms in fermented foods. Front Microbiol (2016) 7:578. doi:10.3389/fmicb.2016.00578
5. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Rev Infect Dis (1940) 10:677-8
6. World Health Organization. WHO's First Global Report on Antibiotic Resistance Reveals Serious, Worldwide Threat to Public Health. (2014). Available from: http://www.who.int/mediacentre/news/releases/2014/amr-report/en/
7. Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res (2011) 134(3):281-94
8. Littmann J, Viens AM. The ethical significance of antimicrobial resistance. Public Health Ethics (2015) 8(3):209-24. doi:10.1093/phe/phv025
9. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother (2009) 64:3-10. doi:10.1093/jac/dkp256
10. Woolhouse M, Ward M, vanBunnik B, Farrar J. Antimicrobial resistance in humans, livestock and the wider environment. Philos Trans R Soc Lond B Biol Sci (2015) 370:20140083. doi:10.1098/rstb.2014.0083
11. Brown K, Uwiera RRE, Kalmokoff ML, Brooks SPJ, Inglis GD. Antimicrobial growth promoter use in livestock: a requirement to understand their modes of action to develop effective alternatives. Int J Antimicrob Agents (2016) 49:12-24. doi:10.1016/j.ijantimicag.2016.08.006
12. Moudgil P, Bedi JS, Moudgil AD, Gill JPS, Aulakh RS. Emerging issue of antibiotic resistance from food producing animals in India: perspective and legal framework. Food Rev Int (2017). doi:10.1080/87559129.2017.1326934
13. Raghunath D. Emerging antibiotic resistance in bacteria with special reference to India. J Biosci (2008) 33(4):593-603. doi:10.1007/s12038-008-0077-9
14. Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging infections program as surveillance for antimicrobial drug resistance. Emerg Infect Dis (2015) 21(9):1578-81. doi:10.3201/eid2109.150512
15. Krehbiel C. The role of new technologies in global food security: improving animal production efficiency and minimizing impacts. Anim Front (2013) 3(3):4-7. doi:10.2527/af.2013-0017
16. Hao H, Cheng G, Iqbal Z, Ai X, Hussain HI, Huang L, et al. Benefits and risks of antimicrobial use in food-producing animals. Front Microbiol (2014) 5:288. doi:10.3389/fmicb.2014.00288
17. Food and Drug Administration. CVM Updates-CVM Reports on Antimicrobials Sold or Distributed for Food-Producing Animals. Maryland: Food Drug Admin, Silver Spring (2010). Available from: https://www.fda.gov/downloads/ForIndustry/UserFees/AnimalDrugUserFeeActADUFA/UCM277657.pdf
18. Lhermie G, Grohn YT, Raboisson D. Addressing antimicrobial resistance: an overview of priority actions to prevent suboptimal antimicrobial use in food-animal production. Front Microbiol (2016) 7:2114. doi:10.3389/fmicb.2016.02114
19. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A (2015) 112(18):5649-54. doi:10.1073/pnas.1503141112
20. Maron DF, Smith TJ, Nachman KE. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey. Global Health (2013) 9:48. doi:10.1186/1744-8603-9-48
21. Kakkar M, Rogawski L. Antibiotic Use and Residues in Chicken Meat and Milk Samples from Karnataka and Punjab, India: Research Scheme 34. New Delhi: Public Health Found (2013)
22. Basnyat B. Antibiotic resistance needs global solutions. Lancet Infect Dis (2014) 14(7):549-50. doi:10.1016/S1473-3099(14)70800-X
23. Brower CH, Mandal S, Hayer S, Sran M, Zehra A, Patel S, et al. The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli in poultry chickens and variation according to farming practices in Punjab, India. Environ Health Perspect (2017) 125(7):077015. doi:10.1289/EHP292
24. Diaz F. Antimicrobial Use in Animals: Analysis of the OIE Survey on Monitoring of the Quantities of Antimicrobial Agents Used in Animals. Paris (2013). Available from: http://www.oie.int/eng/A_AMR2013/Presentations/S2_4_FrançoisDiaz.pdf
25. McManus MC. Mechanisms of bacterial resistance to antimicrobial agents. Am J Health Syst Pharm (1997) 54(12):1420-33
26. Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 44(7):1771-7. doi:10.1128/AAC.44.7.1771-1777.2000
27. Palmer KL, Kos VN, Gilmore MS. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol (2010) 13(5):632-9. doi:10.1016/j.mib.2010.08.004
28. Jeters RT, Wang GR, Moon K, Shoemaker NB, Salyers AA. Tetracycline-associated transcriptional regulation of transfer genes of the Bacteroides conjugative transposon CTnDOT. J Bacteriol (2009) 191(20):6374-82. doi:10.1128/JB.00739-09
29. Bailey JK, Pinyon JL, Anantham S, Hall RM. Distribution of the blaTEM gene and blaTEM-containing transposons in commensal Escherichia coli. J Antimicrob Chemother (2011) 66:745-51. doi:10.1093/jac/dkq529
30. Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, Fluit AC, et al. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis (2003) 9:1108-15. doi:10.3201/eid0909.020383
31. Ramos S, Igrejas G, Rodrigues J, Capelo-Martinez JL, Poeta P. Genetic characterisation of antibiotic resistance and virulence factors in vanA-containing enterococci from cattle, sheep and pigs subsequent to the discontinuation of the use of avoparcin. Vet J (2012) 193:301-3. doi:10.1016/j.tvjl.2011.12.007
32. Cain AK, Liu X, Djordjevic SP, Hall RM. Transposons related to Tn1696 in IncHI2 plasmids in multiply antibiotic resistant Salmonella enterica serovar Typhimurium from Australian animals. Microb Drug Resist (2010) 16:197-202. doi:10.1089/mdr.2010.0042
33. Cain AK, Hall RM. Evolution of a multiple antibiotic resistance region in IncHI1 plasmids: reshaping resistance regions in situ. J Antimicrob Chemother (2012) 67:2848-53. doi:10.1093/jac/dks317
34. Normanno G, Corrente M, La Salandra G, Dambrosio A, Quaglia NC, Parisi A, et al. Methicillin-resistant Staphylococcus aureus (MRSA) in foods of animal origin product in Italy. Int J Food Microbiol (2007) 117(2):219-22. doi:10.1016/j.ijfoodmicro.2007.04.006
35. Normanno G, La Salandra G, Dambrosio A, Quaglia NC, Corrente M, Parisi A, et al. Occurrence, characterization and antimicrobial resistance of enterotoxigenic Staphylococcus aureus isolated from meat and dairy products. Int J Food Microbiol (2007) 115(3):290-6. doi:10.1016/j.ijfoodmicro.2006.10.049
36. Sasidharan S, Prema B, Latha LY. Antimicrobial drug resistance of Staphylococcus aureus in dairy products. Asian Pac J Trop Biomed (2011) 1(2):130-2. doi:10.1016/S2221-1691(11)60010-5
37. Jamali H, Paydar M, Radmehr B, Ismail S, Dadrasnia A. Prevalence and antimicrobial resistance of Staphylococcus aureus isolated from raw milk and dairy products. Food Control (2015) 54:383-8. doi:10.1016/j.foodcont.2015.02.013
38. Harakeh S, Saleh I, Zouhairi O, Baydoun E, Barbour E, Alwan N. Antimicrobial resistance of Listeria monocytogenes isolated from dairy-based food products. Sci Total Environ (2009) 407(13):4022-7. doi:10.1016/j.scitotenv.2009.04.010
39. Rahimi E, Ameri M, Momtaz H. Prevalence and antimicrobial resistance of Listeria species isolated from milk and dairy products in Iran. Food Control (2010) 21(11):1448-52. doi:10.1016/j.foodcont.2010.03.014
40. Sawant AA, Hegde NV, Straley BA, Donaldson SC, Love BC, Knabel SJ, et al. Antimicrobial-resistant enteric bacteria from dairy cattle. Appl Environ Microbiol (2007) 3(1):156-63. doi:10.1128/AEM.01551-0
41. Khan A, Das SC, Ramamurthy T, Sikdar A, Khanam J, Yamasaki S, et al. Antibiotic resistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in Calcutta, India. J Clin Microbiol (2002) 40(6):2009-15. doi:10.1128/JCM.40.6.2009-2015.2002
42. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended spectrum β lactamase producing and AmpC producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect (2012) 18(7):646-55. doi:10.1111/j.1469-0691.2012.03850
43. Carattoli A. Animal reservoirs for extended spectrum β lactamase producers. Clin Microbiol Infect (2008) 14(s1):117-23. doi:10.1111/j.1469-0691.2007.01851.x
44. Addis Z, Kebede N, Sisay Z, Alemayehu H, Wubetie A, Kassa T. Prevalence and antimicrobial resistance of Salmonella isolated from lactating cows and in contact humans in dairy farms of Addis Ababa: a cross sectional study. BMC Infect Dis (2011) 11(1):222. doi:10.1186/1471-2334-11-222
45. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev (2011) 24:718-33. doi:10.1128/CMR.00002-11
46. Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl (2015) 8:240-5. doi:10.1111/eva.12185
47. Coetzee J, Corcoran C, Prentice E, Moodley M, Mendelson M, Poirel L, et al. Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients. S Afr Med J (2016) 106:449-50. doi:10.7196/samj.2016.v106i5.10710
48. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis (2016) 16(2):161-8. doi:10.1016/S1473-3099(15)00424-7
49. Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol (2016) 7:1881. doi:10.3389/fmicb.2016.01881
50. Horigana V, Kosmider RD, Horton RA, Randall L, Simons RRL. An assessment of evidence data gaps in the investigation of possible transmission routes of extended spectrum-lactamase producing Escherichia coli from livestock to humans in the UK. Prev Vet Med (2016) 124:1-8. doi:10.1016/j.prevetmed.2015.12.020
51. Kock R, Kreienbrock L, Van Duijkeren E, Schwarz S. Antimicrobial resistance at the interface of human and veterinary medicine. Vet Microbiol (2016) 200:1-5. doi:10.1016/j.vetmic.2016.11.013
52. Chantziaras I, Boyen F, Callens B, Dewulf J. Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries. J Antimicrob Chemother (2014) 69:827-34. doi:10.1093/jac/dkt443
53. OIE, World Organisation for Animal Health. Aquatic Animal Health Code. 15th ed. Paris: OIE (2012). Available from: www.oie.int/en/international-standard-setting/aquatic-code/
54. OIE, World Organisation for Animal Health. Terrestrial Animal Health Code. 21st ed. Paris: OIE (2012). Available from: http://www.oie.int/international-standard-setting/terrestrial-code/
55. Codex Alimentarius Commission. Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance. CAC/GL 77. Rome: Codex Alimentarius Commission (2011). Available from: www.fao.org/input/download/standards/11776/CXG_077e.pdf
56. Silley P, Simjee S, Schwarz S. Surveillance and monitoring of antimicrobial resistance and antibiotic consumption in humans and animals. Rev Sci Tech (2012) 31(1):105-20. doi:10.20506/rst.31.1.2100
57. Acar JF, Moulin G. Integrating animal health surveillance and food safety: the issue of antimicrobial resistance. Rev Sci Tech (2013) 32(2):383-92. doi:10.20506/rst.32.2.2230
58. Danish Integrated Antimicrobial Resistance Monitoring and Research Programme. Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark. (2005). Available from: https://www.danmap.org/~/media/Projekt%20sites/Danmap/DANMAP%20reports/Danmap_2005.ashx
59. Tollefson L. FDA reveals plans for antimicrobial susceptibility monitoring. J Am Vet Med Assoc (1996) 208:459-60
60. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis (2002) 34:S93-106. doi:10.1086/340246
61. European Medicines Agency. Trends in the Sales of Veterinary Antimicrobial Agents in Nine European Countries (2005-2009) (EMA/238630/2011). London: European Medicines Agency (2011). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/09/WC500112309.pdf
62. de Jong A, Thomas V, Klein U, Marion H, Moyaert H, Simjee S, et al. Pan-European resistance monitoring programmes encompassing food-borne bacteria and target pathogens of food-producing and companion animals. Int J Antimicrob Agents (2013) 41:403-9. doi:10.1016/j.ijantimicag.2012.11.004
63. Martel J, Coudert M. Bacterial resistance monitoring in animals: the French national experiences of surveillance schemes. Vet Microbiol (1993) 35:321-38. doi:10.1016/0378-1135(93)90157-3
64. Moreno MA, Domínguez L, Teshager T, Herrero IA, Porrero MC, de ávila LDSA, et al. Antibiotic resistance monitoring: the Spanish programme. Int J Antimicrob Agents (2000) 14(4):285-90. doi:10.1016/S0924-8579(00)00138-2
65. Porrero MC, Garcia M, Teshager T, Cubillo I, Rivero E, Rigaut D, et al. Veterinary Monitoring of Antimicrobial Resistance in Spain, VAV 2005, 12th Report, Ed. 1. Madrid: CERSA (2006). Available from: www.vigilanciasanitaria.es/en/veterinary-monitoring-ofantimicrobial-resistance-in-spain-vav-2005-twelfthreport/12=320/
66. Public Health Agency of Canada. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). Ottawa, ON: Public Health Agency of Canada (2006). Available from: www.phac-aspc.gc.ca/cipars-picra/index-eng.php
67. Yamamoto T, Hayama Y, Hidano A, Kobayashi S, Muroga N, Ishikawa K, et al. Sampling strategies in antimicrobial resistance monitoring: evaluating how precision and sensitivity vary with the number of animals sampled per farm. PLoS One (2014) 9(1):e87147. doi:10.1371/journal.pone.0087147
68. Ministry of Health and Family Welfare. National Policy for Containment of Antimicrobial Resistance, India. (2011). Available from: http://www.ncdc.gov.in/ab_policy.pdf
69. World Health Organization. Prevention and containment of antimicrobial resistance. Report of a Regional Meeting Chiang Mai, Thailand, 8th to 11th of June 2010. (2010). Available from: http://www.searo.who.int/entity/antimicrobial_resistance/BCT_Reports_SEA-HLM-408.pdf?ua=1
70. Behera B, Mathur P. High levels of antimicrobial resistance at a tertiary trauma care centre of India. Indian J Med Res (2011) 133(3):343-5
71. Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother (2009) 66:1992-7. doi:10.1093/jac/dkr240
72. Borah VV, Saikia KK, Chandra P, Hazarika NK, Chakravarty R. New Delhi metallo-beta-lactamase and extended spectrum beta-lactamases co-producing isolates are high in community-acquired urinary infections in Assam as detected by a novel multiplex polymerase chain reaction assay. Indian J Med Microbiol (2016) 34:173-82. doi:10.4103/0255-0857.176853
73. Tanwar J, Das S, Fatima Z, Hameed S. Multidrug resistance: an emerging crisis. Interdiscip Perspect Infect Dis (2014) 7:541340. doi:10.1155/2014/541340
74. Food and Agriculture Organization of the United Nations. The FAO Action Plan on Antimicrobial Resistance 2016-2020. Rome: Food and Agriculture Organization of the United Nations (2016)
75. World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization (2015)
76. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 13(12):1057-98. doi:10.1016/S1473-3099(13)70318-9
77. DiMasi JA. Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs, Tufts Center for the Study of Drug Development. (2014). Available from: http://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18, _2014.pdf
78. Elder DP, Kuentz M, Holm R. Antibiotic resistance: the need for a global strategy. J Pharm Sci (2016) 105(8):2278-87. doi:10.1016/j.xphs.2016.06.002
79. Cheng G, Hao H, Xie S, Wang X, Dai M, Huang L, et al. Antibiotic alternatives: the substitution of antibiotics in animal husbandry. Front Microbiol (2014) 5:69-83. doi:10.3389/fmicb.2014.00217
80. Mishra RPN, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol (2012) 15(5):596-602. doi:10.1016/j.mib.2012.08.002
81. Merino O, Alberdi P, de la Lastra JMP, de la Fuente J. Tick vaccines and the control of tick-borne pathogens. Front Cell Infect Microbiol (2013) 3:30. doi:10.3389/fcimb.2013.00030
82. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, et al. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science (2015) 348(6241):8205. doi:10.1126/science.aaa8205
83. Wang S, Zeng X, Yang Q, Qiao S. Antimicrobial peptides as potential alternatives to antibiotics in food animal industry. Int J Mol Sci (2016) 17(5):603. doi:10.3390/ijms17050603
84. McVey S, Shi J. Vaccines in veterinary medicine: a brief review of history and technology. Vet Clin North Am Small Anim Pract (2010) 40:381-92. doi:10.1016/j.cvsm.2010.02.001
85. Dellagostin OA, Felix SR, Jorge S. Recombinant veterinary vaccines. In: Soccol VT, Pandey A, Resende R, editors. Current Developments in Biotechnology and Bioengineering, Human and Animal Health Applications. (2017). p. 439-58. doi:10.1016/B978-0-444-63660-7.00017-6
86. Riosa AC, Moutinhob CG, Pinto FC, Del Fiola FS, Jozalaa A, Chauda MV, et al. Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol Res (2016) 191:51-80. doi:10.1016/j.micres.2016.04.008
87. Jensen TH, Nielsen L, Aasted B, Pertoldi C, Blixenkrone-Møller M. Canine distemper virus DNA vaccination of mink can overcome interference by maternal antibodies. Vaccine (2015) 33(11):1375-81. doi:10.1016/j.vaccine.2015.01.029
88. Liu X, Liu Q, Xiao K, Li P, Liu Q, Zhao X, et al. Attenuated Salmonella Typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus. Vet Microbiol (2016) 186:189-98. doi:10.1016/j.vetmic.2016.03.001
89. Shakya M, Kumar B, Nagar G, Fuente J, Ghosh S. Subolesis: a candidate vaccine antigen for the control of cattle tick infestations in Indian situation. Vaccine (2014) 32(28):3488-94. doi:10.1016/j.vaccine.2014.04.053
90. Mcallister MM. Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs. Parasitology (2014) 141(5):624-40. doi:10.1017/S0031182013002060
91. Rizzi C, Bianco MV, Blanco FC, Soria M, Gravisaco MJ, Montenegro V, et al. Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge. PLoS One (2012) 7(12):e51396. doi:10.1371/journal.pone.0051396
92. Potter A, Gerdts V, Littel-van den Hurk SV. Veterinary vaccines: alternatives to antibiotics? Anim Health Res Rev (2008) 9(2):187-99. doi:10.1017/S1466252308001606
93. Tiwari J, Babra C, Tiwari HK, Williams V, De Wet S, Gibson J, et al. Trends in therapeutic and prevention strategies for management of bovine mastitis: an overview. J Vaccines Vaccin (2013) 4(2):1000176. doi:10.4172/2157-7560.1000176
94. Sayed ML, Shell WS, Hanan AA, Hanan MI, Nasr EA, Ali AM. Efficacy of a locally prepared bovine mastitis vaccine. Benha Vet Med J (2015) 29(2):309-18
95. Michon C, Langella P, Eijsink VGH, Mathiesen G, Chatel JM. Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications. Microb Cell Fact (2016) 15:70. doi:10.1186/s12934-016-0468-9
96. Kumar R, Sreenivasa BP, Tamilselvan RP. Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75. Vet World (2015) 8(2):147-55. doi:10.14202/vetworld.2015.147-155
97. Kumar M, Sarvanan P, Jalali SK. Expression and purification of virus like particles (VLPs) of foot and mouth disease virus in Eri silkworm (Samia Cynthia ricini) larve. Virus Dis (2016) 27(1):84-90. doi:10.1007/s13337-015-0290-8
98. Tiwari R, Chakraborty S, Dhama K, Rajagunalan S, Singh SV. Antibiotic resistance-an emerging health problem: causes, worries, challenges and solutions-a review. Int J Curr Res (2013) 5(07):1880-92
99. Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC. Development and registration of recombinant veterinary vaccines: the example of the canarypox vector platform. Vaccine (2007) 25(30):5606-12. doi:10.1016/j.vaccine.2006.11.066
100. Kalayou S, Haileselassie M, Gebre-egziabher G, Tiku'e T, Sahle S, Taddele H, et al. In-vitro antimicrobial activity screening of some ethnoveterinary medicinal plants traditionally used against mastitis, wound and gastrointestinal tract complication in Tigray Region, Ethiopia. Asian Pac J Trop Biomed (2012) 2(7):512-22. doi:10.1016/S2221-1691(12)60088-4
101. Narayana VL, Rao GMN. Ethnoveterinary practices and phytochemical analysis of some selected medicinal plants from north coastal Andhra Pradesh, India. Indian J Appl Res (2015) 5(9):455-7
102. Dhama K, Tiwari R, Chakraborty S, Saminathan M, Kumar A, Karthik K, et al. Evidence based antibacterial potentials of medicinal plants and herbs countering bacterial pathogens especially in the era of emerging drug resistance: an integrated update. Int J pharmacol (2014) 10(1):1-43. doi:10.3923/ijp.2014.1.43
103. Hashemi SR, Davoodi H. Herbalplantsandtheirderivativesas growth and health promoters in animal nutrition. Vet Res Commun (2011) 35:169-80. doi:10.1007/s11259-010-9458-2
104. Abreu AC, McBain AJ, Simoes M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep (2012) 29:1007-21. doi:10.1039/c2np20035j
105. Savoia D. Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol (2012) 7(8):979-90. doi:10.2217/fmb.12.68
106. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv (2015) 33:1582-614. doi:10.1016/j.biotechadv.2015.08.001
107. Taga I, Lan CQ, Altosaar I. Plant essential oils and mastitis disease: their potential inhibitory effects on pro-inflammatory cytokine production in response to bacteria related inflammation. Nat Prod Commun (2012) 7(5):675-82
108. Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update. Food Chem Toxicol (2015) 83:111-24. doi:10.1016/j.fct.2015.05.022
109. Brooks VJ, Peek SF, Godbee RG, Schultz RD, Suresh M, Darien BJ. Effects of Morinda citrifolia (Noni) on CD4+ and CD8+ T-cell activation in neonatal calves. Prof Anim Sci (2009) 25:262-5
110. Yancey JWS, Apple JK, Kegley EB, Goodbee RG. Effects of Morinda citrifolia (Noni) pulp on growth performance and stress responses of growing cattle. Prof Anim Sci (2013) 29(4):420-5. doi:10.15232/S1080-7446(15)30255-2
111. Ghosh S, Mehla RK, Sirohi SK, Roy B. The effect of dietary garlic supplementation on body weight gain, feed intake, feed conversion efficiency, faecal score, faecal coliform count and feeding cost in crossbred dairy calves. Trop Anim Health Prod (2010) 42(5):961-8. doi:10.1007/s11250-009-9514-5
112. Ghosh S, Mehla RK, Sirohi SK, Tomar SK. Performance of crossbred calves with dietary supplementation of garlic extract. J Anim Physiol Anim Nutr (2011) 95(4):449-55. doi:10.1111/j.1439-0396.2010.01071.x
113. Luseba D, Tshisikhawe MP. Medicinal plants used in the treatment of livestock diseases in Vhembe region, Limpopo province, South Africa. J Med Plants Res (2013) 7(10):593-601. doi:10.5897/JMPR012.1213
114. Panda SS, Dhal NK. Plants used in ethno-veterinary medicine by native people of Nawarangpur district, Odisha, India. World J Pharm Pharm Sci (2014) 3(7):787-98
115. Andrade FI, Purgato GA, Maia TF, Siqueira RP, Lima S, Diaz G, et al. Chemical constituents and an alternative medicinal veterinary herbal soap made from Senna macranthera. Evid Based Complement Alternat Med (2015) 2015:217598. doi:10.1155/2015/217598
116. Kinde H, Regassa F, Asaye M, Wubie A. The in-vitro antibacterial effect of three selected plant extracts against Staphylococcus aureus and Streptococcus agalactiae isolated from bovine mastitis. J Vet Sci Technol (2015) 6(13):S13. doi:10.4172/2157-7579.1000S13-001
117. Megeed KNA, Hammam AM, Morsy GH, Khalil FAM, Seliem MME, Aboelsoued D. Control of cryptosporidiosis in buffalo calves using garlic (Allium sativum) and nitazoxanide with special reference to some biochemical parameters. Global Vet (2015) 14(5):646-55. doi:10.5829/idosi.gv.2015.14.05.94137
118. Dantas ACS, Machado DMR, Araujo AC, Oliveira-Junior RG, Lima-Saraiva SRG, Ribeiro LAA, et al. Acaricidal activity of extracts from the leaves and aerial parts of Neoglaziovia variegata (bromeliaceae) on the cattle tick Rhipicephalus (Boophilus) microplus. Res Vet Sci (2015) 100:165-8. doi:10.1016/j.rvsc.2015.04.012
119. Balkrishna A, Kumar HM, Kumari D, Kumari H, Gupta AK. Isolation, screening of mastitis causing bacteria and antibacterial effect of poly herbal formulation. Int J Rec Sci Res (2016) 7(5):11440-4
120. Mushtaq S, Rather MA, Qazi PH, Aga MA, Shah AM, Shah A, et al. Isolation and characterization of three benzylisoquinoline alkaloids from Thalictrum minus L. and their antibacterial activity against bovine mastitis. J Ethnopharmacol (2016) 193:221-6. doi:10.1016/j.jep.2016.07.040
121. Zhu H, Du M, Fox L, Zhu MJ. Bactericidal effects of Cinnamon cassia oil against bovine mastitis bacterial pathogens. Food Control (2016) 66:291-9. doi:10.1016/j.foodcont.2016.02.013
122. Singh MVKG, Mondal DB, Shakya M, Sharma DK. Evaluation of antbacterial and therapeutic potential of Holarrhena antidysenterica bark extract in calf diarrhea. Int J Adv Res (2016) 4(8):1334-9. doi:10.21474/IJAR01/1334
123. Amber R, Adnan M, Tariq A, Khan SN, Mussarat S, Hashem A, et al. Antibacterial activity of selected medicinal plants of northwest Pakistan traditionally used against mastitis in livestock. Saudi J Biol Sci (2017). doi:10.1016/j.sjbs.2017.02.008
124. Medina MFE, Alaba PA, Estrada-Zuniga ME, Velazquez-Ordonez V, Barbabosa-Pliego A, Salem MZ, et al. Anti-staphylococcal properties of four plant extracts against sensitive and multiresistant bacterial strains isolated from cattle and rabbits. Microb Pathog (2017) 113:286-94. doi:10.1016/j.micpath.2017.10.053
125. Sserunkuma P, McGaw LJ, Nsahlai IV, Van Staden J. Selected southern African medicinal plants with low cytotoxicity and good activity against bovine mastitis pathogens. S Afr J Bot (2017) 111:242-7. doi:10.1016/j.sajb.2017.03.032
126. Mudzengi CP, Murwira A, Tivapasi M, Murungweni C, Burumu JV, Halimani T. Antibacterial activity of aqueous and methanol extracts of selected species used in livestock health management. Pharm Biol (2017) 55(1):1054-60. doi:10.1080/13880209.2017.1287744
127. Punniamurthy N, Ramakrishnan N, Nair MNB, Vijayaraghavan S. In-vitro antimicrobial activity of ethnoveterinary herbal preparation for mastitis. J Dairy Vet Sci (2017) 3(2):1-2. doi:10.19080/JDVS.2017.03.555607
128. Pasca C, Marghitas L, Dezmirean D, Bobis O, Bonta V, Chirila F, et al. Medicinal plants based products tested on pathogens isolated from mastitis milk. Molecules (2017) 22:1473. doi:10.3390/molecules22091473
129. El-Desoukey RMA. Phytochemical and antimicrobial activity of Panicum turgidum (thummam) as a grazing herb against some animal pathogens. EC Microbiol (2017) 5(1):22-9
130. Nanon A, Suksombat W, Yang WZ. Effects of essential oils supplementation on in vitro and in situ feed digestion in beef cattle. Anim Feed Sci Technol (2014) 196:50-9. doi:10.1016/j.anifeedsci.2014.07.006
131. Jeshari M, Riasi A, Mahdavi AH, Khorvash M, Ahmadi F. Effect of essential oils and distillation residues blends on growth performance and blood metabolites of Holstein calves weaned gradually or abruptly. Livest Sci (2016) 185:117-22. doi:10.1016/j.livsci.2015.12.011
132. Guil-Guerrero JL, Ramos L, Moreno C, Zúniga-Paredes JC, Carlosama-Yépez M, Ruales P. Antimicrobial activity of plant-food by-products: a review focusing on the tropics. Livest Sci (2016) 189:32-49. doi:10.1016/j.livsci.2016.04.021
133. Guil-Guerrero JL, Ramos L, Moreno C, Zúniga-Paredes JC, Carlosama-Yépez M, Ruales P. Plant-food by-products to improve farm-animal health. Anim Feed Sci Technol (2016) 220:121-35. doi:10.1016/j.anifeedsci.2016.07.016
134. Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med (2007) 53:461-7. doi:10.1055/s-2007-967167
135. Miyasaki Y, Nichola WS, Morgan MA, Kwan JA, Van Benschoten MM, Kittel PE, et al. Screening of herbal extracts against multi-drug resistant Acinetobacter baumannii. Phytother Res (2010) 24:1202-6. doi:10.1002/ptr.3113
136. Kipre BG, Guessennd NK, Kone MW, Gbonon V, Coulibaly JK, Dosso M. Antibacterial activity of the stem bark of Tieghemella heckelii Pierre ex. A Chev against methicillin-resistant Staphylococcus aureus. BMC Complement Altern Med (2017) 17:170. doi:10.1186/s12906-017-1681-8
137. Singh V, Jaryal M, Gupta J, Kumar P. Antibacterial activity of medicinal plants against extended spectrum beta lactamase producing bacteria causing urinary tract infection. Int J Drug Res Technol (2017) 2(3):4
138. Upadhyaya I, Upadhyay A, Kollanoor-Johny A, Mooyottu S, Baskaran SA, Yin HB, et al. In-feed supplementation of trans-cinnamaldehyde reduces layer-chicken egg-borne transmission of Salmonella enterica serovar enteritidis. Appl Environ Microbiol (2015) 81(9):2985-94. doi:10.1128/AEM.03809-14
139. Huyghebaert G, Ducatelle R, VanImmerseel F. An update on alternatives to antimicrobial growth promoters for broilers. Vet J (2011) 187:182-8. doi:10.1016/j.tvjl.2010.03.003
140. Baffoni L, Gaggìa F, di Gioia D, Santini C, Mogna L, Biavati B. A Bifidobacterium-based synbiotic product to reduce the transmission of C. jejuni along the poultry food chain. Int J Food Microbiol (2012) 157(2):156-61. doi:10.1016/j.ijfoodmicro.2012.04.024
141. D'Orazio G, Di Gennaro P, Boccarusso M, Presti I, Bizzaro G, Giardina S, et al. Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study to assess viability and biological properties. Appl Microbiol Biotechnol (2015) 99(22):9779-89. doi:10.1007/s00253-015-6853-1
142. Varankovich NV, Nickerson MT, Korber DR. Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol (2015) 6:685. doi:10.3389/fmicb.2015.00685
143. Imperial IC, Ibana JA. Addressing the antibiotic resistance problem with probiotics: reducing the risk of its double-edged sword effect. Front Microbiol (2016) 7:1983. doi:10.3389/fmicb.2016.01983
144. Tellez G, Laukova A, Latorre JD, Hernandez-Velasco X, Hargis BM, Callaway T. Food-producing animals and their health in relation to human health. Microb Ecol Health Dis (2015) 26:25876. doi:10.3402/mehd.v26.25876
145. Muñoz-Atienza E, Gómez-Sala B, Araújo C, Campanero C, Del Campo R, Hernández PE, et al. Antimicrobial activity, antibiotic susceptibility and virulence factors of lactic acid bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol (2013) 13(1):15. doi:10.1186/1471-2180-13-15
146. Frizzo LS, Soto LP, Zbrun MV, Signorini ML, Bertozzi E, Sequeira G, et al. Effect of lactic acid bacteria and lactose on growth performance and intestinal microbial balance of artificially reared calves. Livest Sci (2011) 140(1):246-52. doi:10.1016/j.livsci.2011.04.002
147. Bayatkouhsar J, Tahmasebi AM, Naserian AA, Mokarram RR, Valizadeh R. Effects of supplementation of lactic acid bacteria on growth performance, blood metabolites and fecal coliform and lactobacilli of young dairy calves. Anim Feed Sci Technol (2013) 186:1-11. doi:10.1016/j.anifeedsci.2013.04.015
148. Allen HK, Levine UY, Looft T, Bandrick M, Casey TA. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals. Trends Microbiol (2013) 21:114-9. doi:10.1016/j.tim.2012.11.001
149. Uyeno Y, Shigemori S, Shimosato T. Effect of probiotics/prebiotics on cattle health and productivity. Microbes Environ (2015) 30(2):126-32. doi:10.1264/jsme2.ME14176
150. Oyetayo VO, Oyetayo FL. Potential of probiotics as biotherapeutic agents targeting the innate immune system. Afr J Biotechnol (2005) 4(2):123-7
151. Casas IA, Dobrogosz WJ. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis (2000) 12(4):247-85. doi:10.1080/08910600050216246-1
152. Musa HH, We SL, Zhu CH, Seri HI, Zhu GQ. The potential benefits of probiotics in animal production and health. J Anim Vet Adv (2009) 8:313-21
153. Retta KS. Role of probiotics in rumen fermentation and animal performance: a review. Int J Livest Prod (2016) 7(5):24-32. doi:10.5897/IJLP2016.0285
154. Jamalifar H, Rahimi HR, Samadi N, Shahverdi AR, Sharifian Z, Hosseini F, et al. Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol (2011) 3(1):21-5
155. Lee DK, Kim MJ, Kang JY, Park JE, Shin HS, Ha NJ. Probiotics with antimicrobial activity against multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Korean J Microbiol (2013) 49(3):245-52. doi:10.7845/kjm.2013.3048
156. Mirnejad R, Vahdati AR, Rashidiani J, Erfani M, Piranfar V. The antimicrobial effect of Lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iran Red Crescent Med (2013) 15(2):122-6. doi:10.5812/ircmj.7454
157. Naderi A, Kasra-Kermanshahi R, Gharavi S, Fooladi AAI, Alitappeh MA, Saffarian P. Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs). Iran J Basic Med Sci (2014) 17(3):201-8
158. Ripamonti B, Tirloni E, Stella S, Bersani C, Agazzi A, Maroccolo S, et al. Effects of a species-specific probiotic formulation on multiresistant Escherichia coli isolates from the gut of veal calves. Czech J Anim Sci (2013) 5:201-7
159. Ahasan ASML, Agazzi A, Invernizzi G, Bontempo V, Savoini G. The beneficial role of probiotics in monogastric animal nutrition and health. J Dairy Vet Anim Res (2015) 2(4):00041. doi:10.15406/jdvar.2015.02.00041
160. Yirga H. The use of probiotics in animal nutrition. J Prob Health (2015) 3:132. doi:10.4172/2329-8901.1000132
161. Gulbe G, Valdovska A, Saulite V, Jermolajevs J. In vitro assessment for antimicrobial activity of Lactobacillus helveticus and its natural glycopeptides against mastitis causing pathogens in dairy cattle. Open Biotechnol J (2015) 9:61-6. doi:10.2174/1874070701509010061
162. Ohya T, Akiba M, Ito H. Use of a trial probiotic product in calves experimentally infected with Escherichia coli O157. Japan Agric Res Q (2001) 35:189-94. doi:10.6090/jarq.35.189
163. Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Isolation of bovine intestinal Lactobacillus plantarum and Pediococcus acidilactici with inhibitory activity against Escherichia coli O157 and F5. J Appl Microbiol (2009) 106(2):393-401. doi:10.1111/j.1365-2672.2008.03959
164. Kim GB, Seo YM, Kim CH, Paik IK. Effect of dietary prebiotic supplementation on the performance, intestinal microflora, and immune response of broilers. Poult Sci (2011) 90(1):75-82. doi:10.3382/ps.2010-00732
165. Nakashimada Y, Michinaka A, Watanabe K, Nishio N, Fujii T. Brewer's yeast cell wall affects microbiota composition and decreases Bacteroides fragilis populations in an anaerobic gut intestinal model. J Biosci Bioeng (2011) 111(2):178-84. doi:10.1016/j.jbiosc.2010.09.005
166. Quigley JD, Kost CJ, Wolfe TA. Effects of spray-dried animal plasma in milk replacers or additives containing serum and oligosaccharides on growth and health of calves. J Dairy Sci (2002) 85(2):413-21. doi:10.3168/jds.S0022-0302(02)74089-7
167. Benyacoub J, Rochat F, Saudan KY, Rochat I, Antille N, Cherbut C, et al. Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J Nutr (2008) 138(1):123-9
168. Baines D, Erb S, Lowe R, Turkington K, Sabau E, Kuldau G, et al. A prebiotic, Celmanax™, decreases Escherichia coli O157: H7 colonization of bovine cells and feed-associated cytotoxicity in vitro. BMC Res Notes (2011) 4(1):110. doi:10.1186/1756-0500-4-110
169. Vandeplas S, Dubois Dauphin R, Beckers Y, Thonart P, Thewis A. Salmonella in chicken: current and developing strategies to reduce contamination at farm level. J Food Prot (2010) 73(4):774-85. doi:10.4315/0362-028X-73.4.774
170. Hamasalim HJ. Synbiotic as feed additives relating to animal health and performance. Adv Microbiol (2016) 6:288-302. doi:10.4236/aim.2016.64028
171. Bomba A, Nemcova R, Mudronova D, Guba P. The possibilities of potentiating the efficacy of probiotics. Trends Food Sci Technol (2002) 13:121-6. doi:10.1016/S0924-2244(02)00129-2
172. Asahara T, Takahashi A, Yuki N, Kaji R, Takahashi T, Nomoto K. Protective effect of a synbiotic against multidrug-resistant Acinetobacter baumannii in a murine infection model. Antimicrob Agents Chemother (2016) 60:3041-50. doi:10.1128/AAC.02928-15
173. Sharma C, Gulati S, Thakur N, Singh BP, Gupta S, Kaur S, et al. Antibiotic sensitivity pattern of indigenous lactobacilli isolated from curd and human milk samples. 3 Biotech (2017) 7:53. doi:10.1007/s13205-017-0682-0
174. Yang SC, Lin CH, Sung CT, Fang JY. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol (2014) 5:241. doi:10.3389/fmicb.2014.00241
175. Umu OC, Bauerl C, Oostindjer M, Pope PB, Hernández PE, Pérez-Martínez G, et al. The potential of class II bacteriocins to modify Gut microbiota to improve host health. PLoS One (2016) 11(10):e0164036. doi:10.1371/journal.pone.0164036
176. Mohanasirivasan V, Suganthi V, Selvarajan E, Subathradevi C. LantibioticNisin: natural preservative from Lactococcus lactis. Int Res J Phar (2012) 3(1):13-9
177. Karpinski TM, Szkaradkiewicz AK. Characteristic of bacteriocines and their application. Pol J Microbiol (2013) 62(3):223-35
178. Bemena LD, Mohamed LA, Fernandes AM, Lee BH. Applications of bacteriocins in food, livestock health and medicine. Int J Curr Microbiol App Sci (2014) 3(12):924-49. doi:10.13140/RG.2.1.3426.2488
179. Tong Z, Zhang Y, Ling J, Ma J, Huang L, Zhang L. In vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis. PLoS One (2014) 9:e89209. doi:10.1371/journal.pone.0089209
180. Ceotto-Vigoder H, Marques SL, Santos IN, Alves MD, Barrias ES, Potter A, et al. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis. J Appl Microbiol (2016) 121:101-14. doi:10.1111/jam.13136
181. McCaughey LC, Ritchie ND, Douce GR, Evans TJ, Walker D. Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection. Sci Rep (2016) 6:30201. doi:10.1038/srep30201
182. Pieterse R, Todorov SD, Dicks LMT. Mode of action and in vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin. Braz J Microbiol (2010) 41:133-45. doi:10.1590/S1517-838220100001000020
183. Klostermann K, Crispie F, Flynn J, Meaney WJ, Paul RR, Hill C. Efficacy of a teat dip containing the bacteriocinlacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis. J Dairy Res (2010) 77:231-8. doi:10.1017/S0022029909990239
184. Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, et al. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A (2010) 107(20):9352-7. doi:10.1073/pnas.0913554107
185. Wirawan RE, Klesse NA, Jack RW, Tagg JR. Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl Environ Microbiol (2006) 72:1148-56. doi:10.1128/AEM.72.2.1148-1156.2006
186. Wirawan RE, Swanson KM, Kleffmann T, Jack RW, Tagg JR. Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. Microbiology (2007) 153:1619-30. doi:10.1099/mic.0.2006/005967-0
187. Wu J, Hu S, Cao L. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother (2007) 51(9):3131-5. doi:10.1128/AAC.00629-07
188. Barboza-Corona JE, de la Fuente-Salcido N, Alva-Murillo N, Ochoa-Zarzosa A, Lopez-Meza JE. Activity of bacteriocins synthesized by Bacillus thuringiensis against Staphylococcus aureus isolates associated to bovine mastitis. Vet Microbiol (2009) 138:179-83. doi:10.1016/j.vetmic.2009.03.018
189. Salvucci E, Saavedra L, Hebert EM, Haro C, Sesma F. Enterocin CRL35 inhibits Listeria monocytogenes in a murine model. Foodborne Pathog Dis (2012) 9(1):68-74. doi:10.1089/fpd.2011.0972
190. Cursino L, Smajs DS, Marda J, Nardi RMD, Nicoli JR, Chartone-Souza E, et al. Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo. J Appl Microbiol (2006) 100:821-9. doi:10.1111/j.1365-2672.2006.02834.x
191. Huang E, Zhang L, Chung YK, Zheng Z, Yousef AE. Characterization and application of enterocin RM6, a bacteriocin from Enterococcus faecalis. Biomed Res Int (2013):206917. doi:10.1155/2013/206917
192. Narayana JL, Chen JY. Antimicrobial peptides: possible anti-infective agents. Peptides (2015) 72:88-94. doi:10.1016/j.peptides.2015.05.012
193. Cheema UB, Younas M, Sultan JI, Iqbal A, Tariq M, Waheed A. Antimicrobial peptides: an alternative of antibiotics in ruminants. Adv Agric Biotechnol (2011) 2:15-21
194. Thacker PA. Alternatives to antibiotics as growth promoters for use in swine production: a review. J Anim Sci Biotechnol (2013) 4:35. doi:10.1186/2049-1891-4-35
195. Brogden KA, Ackermann M, McCray PB, Tack BF. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents (2003) 22(5):465-78. doi:10.1016/S0924-8579(03)00180-8
196. Islas-Rodrìguez AE, Marcellini L, Orioni B, Barra D, Stella L, Mangoni ML. Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria. J Pept Sci (2009) 15(9):607-14. doi:10.1002/psc.1148
197. Metz-Boutigue MH, Goumon Y, Lugardon K, Strub JM, Aunis D. Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol (1998) 18:249-66. doi:10.1023/A:1022573004910
198. Dashper SG, O'Brien-Simpson NM, Cross KJ, Paolini RA, Hoffmann B, Catmull DV, et al. Divalent metal cations increase the activity of the antimicrobial peptide kappacin. Antimicrob Agents Chemother (2005) 49:2322-8. doi:10.1128/AAC.49.6.2322-2328.2005
199. Dashper S, Liu S, Reynolds E. Antimicrobial peptides and their potential as oral therapeutic agents. Int J Pept Res Ther (2007) 13:505-16. doi:10.1007/s10989-007-9094-z
200. Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, et al. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem (1996) 271(45):28533-40. doi:10.1074/jbc.271.45.28533
201. Zhang JX, Zhang SF, Wang TD, Guo XJ, Hu RL. Mammary gland expression of antibacterial peptide genes to inhibit bacterial pathogens causing mastitis. J Dairy Sci (2007) 90:5218-25. doi:10.3168/jds.2007-0301
202. Akalin AS. Dairy-derived antimicrobial peptides: action mechanisms, pharmaceutical uses and production proposals. Trends Food Sci Technol (2014) 36(2):79-95. doi:10.1016/j.tifs.2014.01.002
203. Theolier J, Fliss I, Jean J, Hammami R. Milk AMP: a comprehensive database of antimicrobial peptides of dairy origin. Dairy Sci Technol (2014) 94(2):181-93. doi:10.1007/s13594-013-0153-2
204. Nielsen SD, Beverly RL, Qu Y, Dallas DC. Milk bioactive peptide database: a comprehensive database of milk protein-derived bioactive peptides and novel visualization. Food Chem (2017) 232:673-82. doi:10.1016/j.foodchem.2017.04.056
205. Mandal SM, Bharti R, Porto WF, Gauri SS, Mandal M, Franco OL, et al. Identification of multifunctional peptides from human milk. Peptides (2014) 56:84-93. doi:10.1016/j.peptides.2014.03.017
206. Guerrero A, Dallas DC, Contreras S, Chee S, Parker EA, Sun X, et al. Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk. Mol Cell Proteomics (2014) 13:3343-51. doi:10.1074/mcp.M113.036194
207. Lee JK, Park SC, Hahm KS, Park YK. A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice. Biomaterials (2014) 35(3):1025-39. doi:10.1016/j.biomaterials.2013.10.035
208. Padhi A, Sengupta M, Sengupta S, Roehm KH, Sonawane A. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects. Tuberculosis (2014) 94(4):363-73. doi:10.1016/j.tube.2014.03.011
209. Panwar H. Biologically active components of human and bovine milk as potent antimicrobial agents. J Innov Biol (2014) 1(2):97-104
210. Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie (2009) 91(1):19-29. doi:10.1016/j.biochi.2008.05.015
211. Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, et al. A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida. Biochim Biophys Acta1 (2013) 828(2):677-86. doi:10.1016/j.bbamem.2012.09.021
212. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage (2011) 1(2):66-85. doi:10.4161/bact.1.2.15845
213. Buttimer C, McAuliffe O, Ross RP, Hill C, O'Mahony J, Coffey A. Bacteriophages and bacterial plant diseases. Front Microbiol (2017) 8:34. doi:10.3389/fmicb.2017.00034
214. Weinbauer MG. Ecology of prokaryotic viruses. FEMS Microbiol Rev (2004) 28(2):127-81. doi:10.1016/j.femsre.2003.08.001
215. Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, Delattre AS, Lavigne R. Learning from bacteriophages-advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci (2012) 13(8):699-722. doi:10.2174/138920312804871193
216. Tiwari R, Dhama K, Chakraborty S, Kumar A, Rahal A, Kapoor S. Bacteriophage therapy for safeguarding animal and human health: a review. Pak J Biol Sci (2014) 17(3):301-15. doi:10.3923/pjbs.2014.301.315
217. Hamza A, Perveen S, Abbas Z, Ur Rehman S. The lytic SA phage demonstrates bactericidalactivity against mastitis causing Staphylococcus aureus. Open Life Sci (2016) 11:39-45. doi:10.1515/biol-2016-0005
218. Tiwari R, Hirpurkar SD. Therapeutic potential of lytic phages against chronic wound infections. Indian Vet J (2011) 88:1375-7
219. Sankar P. New therapeutic strategies to control and treatment of bovine mastitis. Vet Med Open J (2016) 1(2):e7-8. doi:10.17140/VMOJ-1-e004
220. Kwiatek M, Parasion S, Mizak L, Gryko R, Bartoszcze M, Kocik J. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol (2012) 157(2):225-34. doi:10.1007/s00705-011-1160-3
221. Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW, Sabour PM. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Chemother (2006) 50(9):2912-8. doi:10.1128/AAC.01630-05
222. O'Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic resistant staphylococci from hospitals. Appl Environ Microb (2005) 71:1836-42. doi:10.1128/AEM.71.4.1836-1842.2005
223. Endersen L, O'Mahony J, Hill C, Ross RP, McAuliffe O, Coffey A. Phage therapy in the food industry. Annu Rev Food Sci Technol (2014) 5:327-49. doi:10.1146/annurev-food-030713-092415
224. Goodridge LD, Bisha B. Phage-based biocontrol strategies to reduce foodborne pathogens in foods. Bacteriophage (2011) 1:30-7. doi:10.4161/bact.1.3.17629
225. Rozema EA, Stephens TP, Bach SJ, Okine EK, Johnson RP, Stanford KIM, et al. Oral and rectal administration of bacteriophages for control of Escherichia coli O157: H7 in feedlot cattle. J Food Prot (2009) 72(2):241-50. doi:10.4315/0362-028X-72.2.241
226. Rivas L, Coffey B, McAuliffe O, McDonnell MJ, Burgess CM, Coffey A, et al. In vivo and ex vivo evaluations of bacteriophages e11/2 and e4/1c for use in the control of Escherichia coli O157: H7. Appl Environ Microbiol (2010) 76(21):7210-6. doi:10.1128/AEM.01530-10
227. Coffey B, Rivas L, Duffy G, Coffey A, Ross RP, McAuliffe O. Assessment of Escherichia coli O157: H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments. Int J Food Microbiol (2011) 147(3):188-94. doi:10.1016/j.ijfoodmicro.2011.04.001
228. Johnson RP, Gyles CL, Huff WE, Ojha S, Huff GR, Rath NC, et al. Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. Anim Health Res Rev (2008) 9(2):201-15. doi:10.1017/S1466252308001576
229. Tiwari R, Chakraborty S, Dhama K, Wani MY, Kumar A, Kapoor S. Wonder world of phages: potential biocontrol agents safeguarding biosphere and health of animals and humans-current scenario and perspectives. Pak J Biol Sci (2014) 17:316-28. doi:10.3923/pjbs.2014.316.328
230. Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature (2002) 418:884-9. doi:10.1038/nature01026
231. Courchesne NM, Parisien A, Lan CQ. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat Biotechnol (2009) 3(1):37-45. doi:10.2174/187220809787172678
232. Tiwari R, Dhama K, Chakraborty S, Kapoor S. Enzybiotics: new weapon in the army of antimicrobials: a review. Asian J Anim Vet Adv (2014) 9(3):144-63. doi:10.3923/ajava.2014.144.163
233. Rodriguez-Rubio L, Martínez B, Donovan DM, Rodríguez A, García P. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol (2013) 39(4):427-34. doi:10.3109/1040841X.2012.723675
234. Rodríguez L, Martínez B, Zhou Y, Rodríguez A, Donovan DM, García P. Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol (2011) 11(1):138. doi:10.1186/1471-2180-11-138
235. Rodriguez-Rubio L, Martínez B, Rodríguez A, Donovan DM, García P. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl Environ Microbiol (2012) 78(7):2241-8. doi:10.1128/AEM.07621-11
236. Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, et al. The phage therapy paradigm: pret-a-porter or sur-mesure? Pharm Res (2011) 28(4):934-7. doi:10.1007/s11095-010-0313-5
237. Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Fortuna W, Letkiewicz S, Szufnarowski K, et al. Clinical aspects of phage therapy. Adv Virus Res (2012) 83:73-121. doi:10.1016/B978-0-12-394438-2.00003-7
238. Nobrega FL, Costa AR, Kluskens LD, Azeredo J. Revisiting phage therapy: new applications for old resources. Trends Microbiol (2015) 23(4):185-91. doi:10.1016/j.tim.2015.01.006
239. Yosef I, Manor M, Qimron U. Counteracting selection for antibiotic-resistant bacteria. Bacteriophage (2016) 6(1):e1096996. doi:10.1080/21597081.2015.1096996
240. Yosef I, Manor M, Kiro R, Qimron U. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A (2015) 112:7267-72. doi:10.1073/pnas.1500107112
241. Beisel CL, Gomaa AA, Barrangou R. A CRISPR design for next-generation antimicrobials. Genome Biol (2014) 15:516. doi:10.1186/s13059-014-0516-x
242. Singh V, Gohil N, Garcia RR, Braddick D, Fofie CK. Recent advances in CRISPR-Cas9 genome editing technology for biological and biomedical investigations. J Cell Biochem (2017) 119(1):81-94. doi:10.1002/jcb.26165
243. Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol (2014) 32:1146-50. doi:10.1038/nbt.3043
244. Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA guided nucleases. Nat Biotechnol (2014) 32(11):1141-5. doi:10.1038/nbt.3011
245. Kennedy EM, Kornepati AVR, Cullen BR. Targeting hepatitis B virus cccDNA using CRISPR/Cas9. Antiviral Res (2015) 123:188-92. doi:10.1016/j.antiviral.2015.10.004
246. Stout E, Klaenhammer T, Barrangou R. CRISPR-Cas technologies and applications in food bacteria. Annu Rev Food Sci Technol (2017) 8:413-37. doi:10.1146/annurev-food-072816-024723
247. Sakai M. Current research status of fish immunostimulants. Aquacult (1999) 172(1):63-92. doi:10.1016/S0044-8486(98)00436-0
248. Song SK, Beck BR, Kim D, Park J, Kim J, Kim HD, et al. Prebiotics as immunostimulants in aquaculture: a review. Fish Shellfish Immunol (2014) 40(1):40-8. doi:10.1016/j.fsi.2014.06.016
249. Masihi KN. Immunomodulators in infectious diseases: panoply of possibilites. Int J Immunopharmacol (2000) 22(12):1083-91. doi:10.1016/S0192-0561(00)00074-6
250. Bricknell I, Dalmo RA. The use of immunostimulants in fish larval aquaculture. Fish Shellfish Immunol (2005) 19(5):457-72. doi:10.1016/j.fsi.2005.03.008
251. Gertsch J, Viveros-Paredes JM, Taylor P. Plant immunostimulants-scientific paradigm or myth? J Ethnopharmacol (2011) 136(3):385-91. doi:10.1016/j.jep.2010.06.044
252. Li T, Na R, Yu P, Shi B, Yan S, Zhao Y, et al. Effects of dietary supplementation of chitosan on immune and antioxidative function in beef cattle. Czech J Anim Sci (2015) 60:38-44. doi:10.17221/7910-CJAS
253. Thacker EL. Immunomodulators, immunostimulants, and immunotherapies in small animal veterinary medicine. Vet Clin North Am Small Anim Pract (2010) 40(3):473-83. doi:10.1016/j.cvsm.2010.01.004
254. Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol (2017) 17:49-59. doi:10.1038/nri.2016.123
255. Dhama K, Chakraborty S, Wani MY, Tiwari R, Barathidasan R. Cytokine therapy for combating animal and human diseases-a review. Res Opin Anim Vet Sci (2013) 3(7):195-208
256. Singh BP, Chauhan RS, Singhal LK. Toll-like receptors and their role in innate immunity. Curr Sci (2003) 85(8):1156-64
257. Brodzki P, Kostro K, Krakowski L, Marczuk J. Inflammatory cytokine and acute phase protein concentrations in the peripheral blood and uterine washings of cows with subclinical endometritis in the late postpartum period. Vet Res Commun (2015) 39(2):143-9. doi:10.1007/s11259-015-9635-4
258. Hossain MK, Paul S, Hossain MM, Islam MR, Alam MGS. Bovine mastitis and its therapeutic strategy doing antibiotic sensitivity test. Austin J Vet Sci Anim Husb (2017) 4(1):1030
259. Daley M, Williams T, Coyle P, Furda G, Dougherty R, Hayes P. Prevention and treatment of Staphylococcus aureus infections with recombinant cytokines. Cytokine (1993) 5(3):276-84. doi:10.1016/1043-4666(93)90015-W
260. Basavaraju M, Sisnity VS, Palaparthy R, Addanki PK. Quorum quenching: signal jamming in dental plaque biofilms. J Dent Sci (2016) 11:349-52. doi:10.1016/j.jds.2016.02.002
261. Tay SB, Yew WS. Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens. Int J Mol Sci (2013) 14(8):16570-99. doi:10.3390/ijms140816570
262. LaSarre B, Federle MJ. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol Mol Biol Rev (2013) 77(1):73-111. doi:10.1128/MMBR.00046-12
263. Chen F, Gao Y, Chen X, Yu Z, Li X. Quorum quenching enzymes and their application in degrading signal molecules to block quorum sensing-dependent infection. Int J Mol Sci (2013) 14(9):17477-500. doi:10.3390/ijms140917477
264. Hirakawa H, Tomita H. Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistance. Front Microbiol (2013) 4:114. doi:10.3389/fmicb.2013.00114
265. Boyen F, Eeckhaut V, Van Immerseel F, Pasmans F, Ducatelle R, Haesebrouck F. Quorum sensing in veterinary pathogens: mechanisms, clinical importance and future perspectives. Vet Microbiol (2009) 135:187-95. doi:10.1016/j.vetmic.2008.12.025
266. Koh CL, Sam CK, Yin WF, Tan LY, Krishnan T, Chong YM, et al. Plant-derived natural products as sources of anti-quorum sensing compounds. Sensors (2013) 13(5):6217-28. doi:10.3390/s130506217
267. Tan LY, Yin WF, Chan KG. Piper nigrum, Piper betle and Gnetum gnemon-natural food sources with anti-quorum sensing properties. Sensors (2013) 13(3):3975-85. doi:10.3390/s130303975
268. Kalia VC, Purohit HJ. Quenching the quorum sensing system: potential antibacterial drug targets. Crit Rev Microbiol (2011) 37(2):121-40. doi:10.3109/1040841X.2010.532479
269. Romero M, Acuna L, Otero A. Patents on quorum quenching: interfering with bacterial communication as a strategy to fight infections. Recent Pat Biotechnol (2012) 6:2-12. doi:10.2174/187220812799789208
270. Bhardwaj AK, Vinothkumar K, Rajpara N. Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance. Recent Pat Antiinfect Drug Discov (2013) 8(1):68-83. doi:10.2174/157489113805290809
271. Cirioni O, Mocchegiani F, Cacciatore I, Vecchiet J, Silvestri C, Baldassarre L, et al. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides (2013) 40:77-81. doi:10.1016/j.peptides.2012.12.002
272. Pariza MW, Cook M. Determining the safety of enzymes used in animal feed. Regul Toxicol Pharmacol (2010) 56:332-42. doi:10.1016/j.yrtph.2009.10.005
273. Ravindran V, Son JH. Feed enzyme technology: present status and future developments. Recent Pat Food Nutr Agric (2011) 3(2):102-9. doi:10.2174/2212798411103020102
274. Adeola O, Cowieson AJ. Board-invited review: opportunities and challenges in using exogenous enzymes to improve nonruminant animal production. J Anim Sci (2011) 89:3189-218. doi:10.2527/jas.2010-3715
275. Colombatto D, Morgavi DP, Furtado AF, Beauchemin KA. Screening of exogenous enzymes for ruminant diets: relationship between biochemical characteristics and in vitro ruminal degradation. J Anim Sci (2003) 81(10):2628-38. doi:10.2527/2003.81102628x
276. Knowlton KF, Taylor MS, Hill SR, Cobb C, Wilson KF. Manure nutrient excretion by lactating cows fed exogenous phytase and cellulase. J Dairy Sci (2007) 90(9):4356-60. doi:10.3168/jds.2006-879
277. Bedford MR, Cowieson AJ. Exogenous enzymes and their effects on intestinal microbiology. Anim Feed Sci Technol (2012) 173:76-85. doi:10.1016/j.anifeedsci.2011.12.018
278. Tewoldebrhan TA, Appuhamy JADRN, Lee JJ, Niu M, Seo S, Jeong S, et al. Exogenous β-mannanase improves feed conversion efficiency and reduces somatic cell count in dairy cattle. J Dairy Sci (2017) 100(1):244-52. doi:10.3168/jds.2016-11017
279. Raguvaran R, Manuja A, Manuja BK. Zinc oxide nanoparticles: opportunities and challenges in veterinary sciences. Immunome Res (2015) 11:2. doi:10.4172/1745-7580.1000095
280. Sharma C, Dhiman R, Rokana N, Panwar H. Nanotechnology: an untapped resource for food packaging. Front Micrbiol (2017) 8:1735. doi:10.3389/fmicb.2017.01735
281. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine (2012) 7:2767-81. doi:10.2147/IJN.S24805
282. Gomes F, Henriques M. Control of bovine mastitis: old and recent therapeutic approaches. Curr Microbiol (2016) 72:377-82. doi:10.1007/s00284-015-0958-8
283. Hajipour MJ, Fromm KM, Ashkarran AA, de Aberasturi DJ, de Larramendi IR, Rojo T, et al. Antibacterial properties of nanoparticles. Trends Biotechnol (2012) 30(10):499-511. doi:10.1016/j.tibtech.2012.06.004
284. Yah CS, Simate GS. Nanoparticles as potential new generation broad spectrum antimicrobial agents. DARU J Pharm Sci (2015) 23:43. doi:10.1186/s40199-015-0125-6
285. Cardozo VF, Lancheros CA, Narciso AM, Valereto EC, Kobayashi RK, Seabra AB, et al. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis. Int J Pharm (2014) 473(1-2):20-9. doi:10.1016/j.ijpharm.2014.06.051
286. Dehkordi SH, Hosseinpour F, Kahrizangi AE. An in vitro evaluation of antibacterial effect of silver nanoparticles on Staphylococcus aureus isolated from bovine subclinical mastitis. Afr J Biotechnol (2011) 10(52):10795-7. doi:10.5897/AJB11.1499
287. Xuefeng Y, Wuqing O, Jiangcai S, XiangHui L. Post-antibiotic effect of amoxicillin nanoparticles against main pathogenic bacteria of bovine mastitis in vitro. J Northwest AF Univ (2009) 37(6):1-6
288. Berni E, Marcato PD, Nakazato G, Kobayashi RKT, Vacchi FI, Umbuzeiro GA, et al. Violacein/poly (e-caprolactone)/chitosan nanoparticles against bovine mastistis: antibacterial and ecotoxicity evaluation. J Phys Conf Ser (2013) 429(1):2030. doi:10.1088/1742-6596/429/1/012030
289. Kazemi J, Malahat A, Habib D, Saei M, Adib H. Antibacterial effect of silver nanoparticles along with protein synthesis-inhibiting antibiotics on Staphylococcus aureus isolated from cattle mastitis. Biol J Micro (2014) 8:15-22
290. Kar D, Bandyopadhyay S, Dimri U, Mondal DB, Nanda PK, Das AK, et al. Antibacterial effect of silver nanoparticles and capsaicin against MDR-ESBL producing Escherichia coli: an in vitro study. Asian Pac J Trop Dis (2016) 6(10):807-10. doi:10.1016/S2222-1808(16)61135-0
291. Alizadeh H, Salouti M, Shapouri R. Bactericidal effect of silver nanoparticles on intramacrophage Brucella abortus 544. Jundishapur J Microbiol (2014) 7(3):e9039. doi:10.5812/jjm.9039
292. El-Diasty EM, Ahmed MA, Okasha N, Mansour SF, El-Dek S, El-Khalek HM, et al. Antifungal activity of zinc oxide nanoparticles against dermatophytic lesions of cattle. Rom J Biophys (2013) 23(3):191-202
293. Atef HA, Oraby NH, El-Dahshan EME, Ali MA. Antimicrobial potential of iron oxide nanoparticles in control of some causes of microbial skin affection in cattle. Eur J Acad Essays (2015) 2(6):20-31
294. Thu HM, Myat TW, Win MM, Thant KZ, Rahman S, Umeda K, et al. Chicken egg yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: a concise review. Korean J Food Sci Anim Resour (2017) 37(1):1-9. doi:10.5851/kosfa.2017.37.1.1
295. Fink AL, Williams KL, Harris E, Alvine TD, Henderson T, Schiltz J, et al. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement. PLoS Negl Trop Dis (2017) 11(7):e0005721. doi:10.1371/journal.pntd.0005721
296. Zhang Y, Yin J, Li T, Zhou B, Xu P, Che R, et al. A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection. Res Vet Sci (2017) 114:194-201. doi:10.1016/j.rvsc.2017.04.003
297. Rahman S, Nguyen S, Icatlo F, Umeda K, Kodama Y. Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother (2013) 9:1039-48. doi:10.4161/hv.23383
298. Bhattacharyya T, Sharma A, Akhter J, Pathania R. The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition. Int J Antimicrob Agents (2017) 50(2):219-26. doi:10.1016/j.ijantimicag.2017.03.005
299. Lu HD, Yang SS, Wilson BK, McManus SA, Chen CVH, Prud'homme RK. Nanoparticle targeting of Gram-positive and Gram-negative bacteria for magnetic-based separations of bacterial pathogens. Appl Nanosci (2017) 7(3-4):83-93. doi:10.1007/s13204-017-0548-0